Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis
- PMID: 16200602
- DOI: 10.1002/art.21284
Similar cell surface expression of beta2-microglobulin-free heavy chains by HLA-B27 subtypes differentially associated with ankylosing spondylitis
Abstract
Objective: To determine whether the cell surface features of HLA-B27 subtypes reported to be differentially associated with ankylosing spondylitis (AS) differ in a way that correlates with disease susceptibility.
Methods: Human cell transfectants expressing or lacking the transporter associated with antigen processing were used to determine the cell surface expression of B27 subtypes by flow cytometry with antibodies recognizing the B27 heterodimer or beta2-microglobulin (beta2m)-free heavy chains.
Results: In lymphoid cells with an intact peptide-loading complex, all B27 subtypes, irrespective of their association with disease, showed similar ratios of free heavy chain to heterodimer, suggesting similar surface stability. A substantial decrease in dissociated heavy chains, which never reached 100%, was observed upon addition of a B27 ligand, with no significant differences among subtypes. This is compatible with similar surface expression of irreversible beta2m-free heavy chain forms among subtypes differentially associated with disease. In cells lacking the transporter associated with antigen processing, both disease-associated and non-disease-associated subtypes expressed a population of heterodimers at 26 degrees C that was less stable than the population expressed at 37 degrees C. In the presence of exogenous peptide, the expression of heterodimers increased, without a concomitant decrease in beta2m-free heavy chains. This suggests that in these cells, and for all subtypes tested, most of the dissociated heavy chains at the cell surface are in irreversible forms. At 37 degrees C, the expression of beta2m-free B27 heavy chains was very low on T2 transfectant cells.
Conclusion: HLA-B27 subtypes showing differential associations with AS are similar in their extent of beta2m dissociation and surface expression of free heavy chains.
Similar articles
-
Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis.Arthritis Rheum. 2008 Feb;58(2):401-12. doi: 10.1002/art.23164. Arthritis Rheum. 2008. PMID: 18240209
-
Free HLA class I heavy chain-carrying monocytes--a potential role in the pathogenesis of spondyloarthropathies.J Rheumatol. 2002 May;29(5):966-72. J Rheumatol. 2002. PMID: 12022359
-
HLA-B27 lacking associated beta2-microglobulin rearranges to auto-display or cross-display residues 169-181: a novel molecular mechanism for spondyloarthropathies.FEBS Lett. 2004 Sep 24;575(1-3):1-8. doi: 10.1016/j.febslet.2004.08.037. FEBS Lett. 2004. PMID: 15388324
-
What is the role of HLA-B27 in spondyloarthropathies?Autoimmun Rev. 2011 Jun;10(8):464-8. doi: 10.1016/j.autrev.2011.01.011. Epub 2011 Feb 4. Autoimmun Rev. 2011. PMID: 21296192 Review.
-
Major histocompatibility genes and ankylosing spondylitis.Best Pract Res Clin Rheumatol. 2006 Jun;20(3):601-9. doi: 10.1016/j.berh.2006.03.004. Best Pract Res Clin Rheumatol. 2006. PMID: 16777585 Review.
Cited by
-
Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?Biomolecules. 2023 Jul 28;13(8):1178. doi: 10.3390/biom13081178. Biomolecules. 2023. PMID: 37627243 Free PMC article. Review.
-
A common minimal motif for the ligands of HLA-B*27 class I molecules.PLoS One. 2014 Sep 30;9(9):e106772. doi: 10.1371/journal.pone.0106772. eCollection 2014. PLoS One. 2014. PMID: 25268942 Free PMC article.
-
CXCR1/CXCR2 antagonism is effective in pulmonary defense against Klebsiella pneumoniae infection.Biomed Res Int. 2013;2013:720975. doi: 10.1155/2013/720975. Epub 2013 Mar 18. Biomed Res Int. 2013. PMID: 23586055 Free PMC article.
-
Ankylosing spondylitis is linked to Klebsiella--the evidence.Clin Rheumatol. 2007 Jun;26(6):858-64. doi: 10.1007/s10067-006-0488-7. Epub 2006 Dec 21. Clin Rheumatol. 2007. PMID: 17186116 Review.
-
Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.Mol Cell Proteomics. 2019 Aug;18(8):1491-1510. doi: 10.1074/mcp.RA119.001515. Epub 2019 May 15. Mol Cell Proteomics. 2019. PMID: 31092671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials